Valuation : Lonza Group AG

Market Cap 40.75B 50.14B 43.26B 37.13B 69.39B 4,736B 69.91B 482B 187B 2,422B 188B 184B 7,955B P/E 2026 *
34.1x
P/E 2027 * 28.3x
Enterprise Value 43.54B 53.58B 46.22B 39.67B 74.15B 5,061B 74.71B 515B 200B 2,588B 201B 197B 8,500B EV / Sales 2026 *
6.11x
EV / Sales 2027 * 5.46x
Free-Float
99.36%
Yield 2026 *
0.94%
Yield 2027 * 1.09%
1 day-0.55%
1 week-1.43%
Current month+0.59%
1 month+3.53%
3 months+18.63%
6 months+11.93%
Current year+7.85%
1 week 572
Extreme 572
591.6
1 month 552.8
Extreme 552.8
597.8
Current year 454.6
Extreme 454.6
597.8
1 year 454.6
Extreme 454.6
597.8
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 156.2
Extreme 156.2
785.4
Manager TitleAgeSince
Chief Executive Officer 54 2024-06-30
Director of Finance/CFO 54 2021-11-30
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Director/Board Member 67 2016-04-25
Director/Board Member 66 2018-05-03
Director/Board Member 60 2022-05-04
Date Insider Type Main position Quantity % Market Cap. Importance
5/8/26 Buy 460 0.0007%
5/8/26 Buy 618 0.0009%
3/11/26 Sell 179 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.55%-1.43%+1.65%+17.10% 50.14B
-0.30%-2.88%+429.29%+496.95% 44.85B
+2.13%+0.89%+43.59%+17.61% 43.43B
+0.87%-3.73%+8.96%+73.17% 41.14B
-0.90%-3.67%+14.26%+48.44% 32.92B
+2.71%+6.82% - - 17.56B
+1.68%-4.20%+25.28%+116.83% 16.55B
+0.91%+0.60%+16.83%+29.25% 14.65B
+3.34%-1.13%+80.94%+39.19% 13.93B
-0.97%-5.38%-10.12%-39.15% 12.33B
Average +0.89%-1.30%+67.85%+88.82% 28.75B
Weighted average by Cap. +0.63%-1.39%+87.92%+114.62%

Financials

2026 *2027 *
Net sales 7.13B 8.77B 7.57B 6.5B 12.14B 829B 12.23B 84.42B 32.76B 424B 32.95B 32.23B 1,392B 7.96B 9.79B 8.45B 7.25B 13.55B 925B 13.65B 94.19B 36.55B 473B 36.76B 35.96B 1,553B
Net income 1.21B 1.49B 1.29B 1.11B 2.07B 141B 2.08B 14.38B 5.58B 72.2B 5.61B 5.49B 237B 1.43B 1.76B 1.52B 1.3B 2.43B 166B 2.45B 16.93B 6.57B 84.97B 6.61B 6.46B 279B
Net Debt 2.79B 3.44B 2.97B 2.55B 4.76B 325B 4.79B 33.08B 12.84B 166B 12.91B 12.63B 545B 2.69B 3.3B 2.85B 2.45B 4.57B 312B 4.61B 31.79B 12.34B 160B 12.41B 12.14B 524B
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
20,141
Date Price Change Volume
26-09-03 CHF 579.80 -0.62% 19,752
26-09-02 CHF 583.40 +0.97% 107,310
26-09-01 CHF 577.80 +0.21% 99,501
26-08-31 CHF 576.60 -1.23% 193,007
26-08-28 CHF 583.80 -0.78% 75,798
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
583.40CHF
Average target price
685.13CHF
Spread / Average Target
+17.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LONN Stock